-axo-
cergutuzumab
evolocumab
bispecific
Forssman antibody
atezolizumab
heterophil antibody
antiantibody
idiospecific
heterophile antibody
reagin
antigenomic
conatumumab
panitumumab
drozitumab
intrabody
polyantibody
antigenic
-ab
alloantibody
bococizumab
sulesomab
oleclumab
zolimomab
biciromab
immunospecific
complement
polyvalent
agonistic monoclonal antibody
-a-
-i-
antihuman
bezlotoxumab
Ab
immunoprobe
antisynthetase
polytypic
monoclonal
presentation
olendalizumab
polyantigenic
siltuximab
multiantigen
brentuximab
properdin
antipolyvalent
immunoprecipitant
immunonaive
robatumumab
onartuzumab